Premier Alternatives

Merida Biosciences

Biotech · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. Merida Biosciences is based in Cambridge, MA and was founded in 2022. It was valued at $228 million at its early-stage round in Apr 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $121 million Series A in Apr 2025.

PMV mark · valuation
$228.0M
Oct 2026
Priced at
its early-stage round
Apr 2025
Total raised
$154.0M
Last round
Series A
Apr 2025
How much has Merida Biosciences raised?
$154.0Macross 1 recorded rounds · Apr 2025 – Apr 2025

Most recently, Merida Biosciences raised $121.0M in its Series A (Apr 2025).

Free account
More of Merida Biosciences with a free account
  • ·Everyone on the team, board and advisors included
  • ·Watch Merida Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Merida Biosciences round by round

1 rounds
Apr 2025Series A$121.0M▮

How much has Merida Biosciences raised?

Merida Biosciences has raised $154 million in total; 1 of its rounds is on record. The largest on record was a $121 million Series A in Apr 2025.

Merida Biosciences investors

6 investors are on record for Merida Biosciences, including GV, The Engine, Perceptive Advisors and Bain Capital Life Sciences.

For fundraisers
Raising for a company like Merida Biosciences?

6 investors have backed Merida Biosciences — start your target list with the firms already writing checks in biotech.

See all 6 investors →

Frequently asked about Merida Biosciences

How much has Merida Biosciences raised?
Merida Biosciences has raised $154.0M in total across 1 recorded funding rounds.
When was Merida Biosciences's last funding round?
Merida Biosciences's most recent recorded round was Series A in Apr 2025, raising $121.0M.